Halia Therapeutics logo

Halia Therapeutics Funding & Investors

Halia Therapeutics is a preclinical-stage biopharmaceutical company manufacturing novel therapies to improve the lives of patients with inflammatory disorders and neurological diseases. Halia Therapeutics does this by advancing innovative medicines that target the immune system's response to resolve... Read more

haliatx.com

Total Amount Raised: $47,223,332

Halia Therapeutics Funding Rounds

  • Series C

    $30,000,000

    Series C Investors

    Todd Pedersen
  • Series Unknown

    $12,223,338

  • Series Unknown

    $4,999,994

Funding info provided by Diffbot.